Stock Analysts’ updated eps estimates for Wednesday, December 4th:
Adeia (NASDAQ:ADEA) had its buy rating reaffirmed by analysts at BWS Financial. BWS Financial currently has a $16.00 target price on the stock.
Amazon.com (NASDAQ:AMZN) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $250.00 target price on the stock.
AutoZone (NYSE:AZO) had its buy rating reiterated by analysts at Guggenheim.
Couchbase (NASDAQ:BASE) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $25.00 target price on the stock.
Couchbase (NASDAQ:BASE) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $25.00 price target on the stock.
Couchbase (NASDAQ:BASE) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $22.00 price target on the stock.
Couchbase (NASDAQ:BASE) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $21.00 target price on the stock.
Couchbase (NASDAQ:BASE) had its buy rating reiterated by analysts at Guggenheim. Guggenheim currently has a $30.00 price target on the stock.
Biohaven (NYSE:BHVN) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $61.00 price target on the stock, up from their previous price target of $58.00.
BOX (NYSE:BOX) had its underperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $21.00 price target on the stock.
Coherus BioSciences (NASDAQ:CHRS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $7.00 price target on the stock.
Checkpoint Therapeutics (NASDAQ:CKPT) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $20.00 price target on the stock.
Core & Main (NYSE:CNM) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $62.00 target price on the stock, up from their previous target price of $53.00.
Campbell Soup (NASDAQ:CPB) had its overweight rating reiterated by analysts at Stephens.
Campbell Soup (NASDAQ:CPB) had its neutral rating reaffirmed by analysts at DA Davidson. The firm currently has a $51.00 price target on the stock.
Salesforce (NYSE:CRM) had its outperform rating reaffirmed by analysts at Northland Securities. Northland Securities currently has a $440.00 target price on the stock, up from their previous target price of $400.00.
Salesforce (NYSE:CRM) had its buy rating reiterated by analysts at Truist Financial Co.. Truist Financial Co. currently has a $400.00 price target on the stock, up from their previous price target of $380.00.
Salesforce (NYSE:CRM) had its neutral rating reaffirmed by analysts at Guggenheim.
Salesforce (NYSE:CRM) had its outperform rating reaffirmed by analysts at Oppenheimer Holdings Inc.. The firm currently has a $415.00 price target on the stock, up from their previous price target of $385.00.
Ceragon Networks (NASDAQ:CRNT) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $6.00 target price on the stock, up from their previous target price of $4.50.
Dollar Tree (NASDAQ:DLTR) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $75.00 price target on the stock.
Ecovyst (NYSE:ECVT) had its buy rating reaffirmed by analysts at BWS Financial. BWS Financial currently has a $12.00 price target on the stock.
Enbridge (NYSE:ENB) (TSE:ENB) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $63.00 target price on the stock, up from their previous target price of $59.00.
Forte Biosciences (NASDAQ:FBRX) had its buy rating reaffirmed by analysts at Chardan Capital. They currently have a $64.00 target price on the stock.
Foot Locker (NYSE:FL) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $27.00 price target on the stock.
GoDaddy (NYSE:GDDY) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $230.00 price target on the stock, up from their previous price target of $190.00.
G-III Apparel Group (NASDAQ:GIII) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $32.00 price target on the stock.
Greencore Group (LON:GNC) had its house stock rating reiterated by analysts at Shore Capital.
Guidewire Software (NYSE:GWRE) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $210.00 price target on the stock.
Haemonetics (NYSE:HAE) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $108.00 target price on the stock.
Hanmi Financial (NASDAQ:HAFC) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $29.00 target price on the stock, up from their previous target price of $24.00.
Huntington Bancshares (NASDAQ:HBAN) had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $20.00 target price on the stock, up from their previous target price of $18.50.
Heron Therapeutics (NASDAQ:HRTX) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $4.00 target price on the stock.
Heidrick & Struggles International (NASDAQ:HSII) had its hold rating reaffirmed by analysts at Truist Financial Co.. They currently have a $42.00 target price on the stock, up from their previous target price of $40.00.
International Consolidated Airlines Group (LON:IAG) had its buy rating reiterated by analysts at JPMorgan Chase & Co..
Invinity Energy Systems (LON:IES) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 40 ($0.51) target price on the stock.
iomart Group (LON:IOM) had its buy rating reaffirmed by analysts at Shore Capital.
IQVIA (NYSE:IQV) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $270.00 target price on the stock.
Keros Therapeutics (NASDAQ:KROS) had its buy rating reissued by analysts at Guggenheim.
MARA (NASDAQ:MARA) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $28.00 price target on the stock.
Marston’s (LON:MARS) had its buy rating reiterated by analysts at Shore Capital.
ME Group International (LON:MEGP) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 270 ($3.42) price target on the stock.
Marvell Technology (NASDAQ:MRVL) had its buy rating reissued by analysts at Stifel Nicolaus. The firm currently has a $125.00 price target on the stock, up from their previous price target of $114.00.
Marvell Technology (NASDAQ:MRVL) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $135.00 price target on the stock, up from their previous price target of $115.00.
Marvell Technology (NASDAQ:MRVL) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $120.00 target price on the stock, up from their previous target price of $100.00.
M&T Bank (NYSE:MTB) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. The firm currently has a $223.50 target price on the stock, up from their previous target price of $215.00.
Nextech3D.AI (OTCMKTS:NEXCF) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $0.25 target price on the stock.
OceanFirst Financial (NASDAQ:OCFC) had its neutral rating reiterated by analysts at DA Davidson. DA Davidson currently has a $22.00 target price on the stock.
Old Dominion Freight Line (NASDAQ:ODFL) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $240.00 target price on the stock.
Okta (NASDAQ:OKTA) had its market perform rating reaffirmed by analysts at JMP Securities.
Okta (NASDAQ:OKTA) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $101.00 target price on the stock.
Okta (NASDAQ:OKTA) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $130.00 target price on the stock.
Okta (NASDAQ:OKTA) had its hold rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $92.00 target price on the stock, up from their previous target price of $80.00.
Okta (NASDAQ:OKTA) had its buy rating reiterated by analysts at Westpark Capital. They currently have a $140.00 target price on the stock.
On the Beach Group (LON:OTB) had its buy rating reiterated by analysts at Shore Capital.
Ovid Therapeutics (NASDAQ:OVID) had its buy rating reissued by analysts at HC Wainwright. They currently have a $3.00 price target on the stock.
Blue Owl Capital (NYSE:OWL) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $27.00 target price on the stock.
Oxford Industries (NYSE:OXM) had its market perform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $86.00 target price on the stock.
Paragon Banking Group (LON:PAG) had its buy rating reaffirmed by analysts at Shore Capital.
Pacira BioSciences (NASDAQ:PCRX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $39.00 target price on the stock.
Palantir Technologies (NYSE:PLTR) had its underperform rating reiterated by analysts at William Blair.
Pinnacle Financial Partners (NASDAQ:PNFP) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $135.00 price target on the stock, up from their previous price target of $115.00.
Prenetics Global (NASDAQ:PRE) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $9.00 price target on the stock.
Pure Storage (NYSE:PSTG) had its market perform rating reissued by analysts at Northland Securities. The firm currently has a $63.00 price target on the stock, up from their previous price target of $59.00.
RH (NYSE:RH) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $425.00 target price on the stock.
Cartesian Therapeutics (NASDAQ:RNAC) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $45.00 price target on the stock, up from their previous price target of $41.00.
Roku (NASDAQ:ROKU) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $100.00 target price on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $69.00 price target on the stock.
Savannah Energy (LON:SAVE) had its under review rating reissued by analysts at Shore Capital.
Stitch Fix (NASDAQ:SFIX) had its market perform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $4.00 price target on the stock.
The Sage Group (LON:SGE) had its hold rating reaffirmed by analysts at Shore Capital.
Synopsys (NASDAQ:SNPS) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $635.00 price target on the stock.
SSP Group (LON:SSPG) had its house stock rating reiterated by analysts at Shore Capital.
System1 Group (LON:SYS1) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 840 ($10.64) price target on the stock.
Teladoc Health (NYSE:TDOC) had its overweight rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $13.00 target price on the stock, up from their previous target price of $11.00.
Terns Pharmaceuticals (NASDAQ:TERN) had its neutral rating reissued by analysts at HC Wainwright. They currently have a $7.50 target price on the stock.
Terns Pharmaceuticals (NASDAQ:TERN) had its market outperform rating reiterated by analysts at JMP Securities. JMP Securities currently has a $20.00 price target on the stock.
Thryv (NASDAQ:THRY) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $28.00 price target on the stock.
Topps Tiles (LON:TPT) had its hold rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 42 ($0.53) price target on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its buy rating reissued by analysts at HC Wainwright.
Trevi Therapeutics (NASDAQ:TRVI) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $21.00 price target on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $8.00 price target on the stock.
Uber Technologies (NYSE:UBER) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $95.00 price target on the stock.
Windtree Therapeutics (NASDAQ:WINT) had its neutral rating reiterated by analysts at HC Wainwright. The firm currently has a $7.00 target price on the stock.
Warner Music Group (NASDAQ:WMG) had its buy rating reiterated by analysts at Guggenheim. They currently have a $44.00 price target on the stock.
Willis Towers Watson Public (NASDAQ:WTW) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $380.00 price target on the stock, up from their previous price target of $365.00.
TeraWulf (NASDAQ:WULF) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $11.00 price target on the stock.
XPO (NYSE:XPO) had its overweight rating reiterated by analysts at Stephens. They currently have a $165.00 price target on the stock.
YPF Sociedad Anónima (NYSE:YPF) had its neutral rating reaffirmed by analysts at UBS Group AG. The firm currently has a $38.00 target price on the stock, up from their previous target price of $30.00.
Zephyr Energy (LON:ZPHR) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 13 ($0.16) target price on the stock.
Receive News & Ratings for Adeia Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeia Inc and related companies with MarketBeat.com's FREE daily email newsletter.
